A comparative analysis of patient profiles and health services utilization between patent medicine vendors and community pharmacists in Nigeria
- Adepoju, Victor Abiola, Oladimeji, Olanrewaju
- Authors: Adepoju, Victor Abiola , Oladimeji, Olanrewaju
- Date: 2023/09
- Subjects: Tuberculosis , Patent medicine vendors , Drug shops , Community pharmacist , Service utilization , Signs and symptoms
- Language: English
- Type: Article
- Identifier: http://hdl.handle.net/11260/13169 , vital:78005 , DOI: https://doi.org/10.3390/healthcare11182484
- Description: Background: This study examined Nigeria’s socio-demographic profiles and health service utilization patterns of Patent Medicine Vendors (PMVs) and Community Pharmacists (CPs). Method: A cross-sectional study using a structured self-administered questionnaire among 405 retail outlets (322 PMVs and 83 CPs) across 16 Lagos and Kebbi Local Government Areas (LGAs) between June 2020 and December 2020. Results: Results showed that 60.4% were male, 76.3% from Lagos, 58.3% had tertiary education, and 74.1% had medical training. Cough and fever were common symptoms. Significant differences were found in the utilization of STD services (PMVs: 9.2%, CPs: 12.3%, p = 0.03)), services by age < 0.001), and utilization by males (PMVs: 50.8, CPs: 47.1, p = 0.013). The study revealed that men visited PMVs more, while CPs used more STI services and childhood visits. Conclusions: The findings suggest that expanding health services among PMVs could target male-dominant diseases, and capacity building of CPs on syndromic STI management could reduce the STI burden.
- Full Text:
- Date Issued: 2023/09
- Authors: Adepoju, Victor Abiola , Oladimeji, Olanrewaju
- Date: 2023/09
- Subjects: Tuberculosis , Patent medicine vendors , Drug shops , Community pharmacist , Service utilization , Signs and symptoms
- Language: English
- Type: Article
- Identifier: http://hdl.handle.net/11260/13169 , vital:78005 , DOI: https://doi.org/10.3390/healthcare11182484
- Description: Background: This study examined Nigeria’s socio-demographic profiles and health service utilization patterns of Patent Medicine Vendors (PMVs) and Community Pharmacists (CPs). Method: A cross-sectional study using a structured self-administered questionnaire among 405 retail outlets (322 PMVs and 83 CPs) across 16 Lagos and Kebbi Local Government Areas (LGAs) between June 2020 and December 2020. Results: Results showed that 60.4% were male, 76.3% from Lagos, 58.3% had tertiary education, and 74.1% had medical training. Cough and fever were common symptoms. Significant differences were found in the utilization of STD services (PMVs: 9.2%, CPs: 12.3%, p = 0.03)), services by age < 0.001), and utilization by males (PMVs: 50.8, CPs: 47.1, p = 0.013). The study revealed that men visited PMVs more, while CPs used more STI services and childhood visits. Conclusions: The findings suggest that expanding health services among PMVs could target male-dominant diseases, and capacity building of CPs on syndromic STI management could reduce the STI burden.
- Full Text:
- Date Issued: 2023/09
Stocking Practices of Anti-Tuberculosis Medications among Community Pharmacists and Patent Proprietary Medicine Vendors in Two States in Nigeria
- Adepoju, Abiola Victor, Ademola, Adelekan, Oladimeji, Olanrewaju
- Authors: Adepoju, Abiola Victor , Ademola, Adelekan , Oladimeji, Olanrewaju
- Date: 2023/02
- Subjects: Tuberculosis , Patent medicine vendors , Community pharmacists , Anti-TB medication , Stocking , Dispensing , Fixed-dose combination
- Language: English
- Type: Article
- Identifier: http://hdl.handle.net/11260/13378 , vital:78665 , DOI: 10.3390/healthcare11040584
- Description: Background: Evidence has shown that non-fixed-dose combination (non-FDC) anti-TB drugs could promote the spread of drug-resistant tuberculosis (DR-TB). We aimed to determine anti-TB medication stocking and dispensing practices among patent medicine vendors (PMVs) and community pharmacists (CPs) and their determinants. Method: This was a cross-sectional study using a structured, self-administered questionnaire among 405 retail outlets (322 PMVs and 83 CPs) across 16 Lagos and Kebbi local government areas (LGAs) between June 2020 and December 2020. Data were analyzed with Statistical Program for Social Sciences (SPSS) for Windows version 17 (IBM Corp., Armonk, NY, USA). Chi-square test and binary logistic regression were used to assess the determinants of anti-TB medication stocking practices at a p-value of 0.05 or less for statistical significance. Results: Overall, 91%, 71%, 49%, 43% and 35% of the respondents reported stocking loose rifampicin, streptomycin, pyrazinamide, isoniazid and ethambutol tablets, respectively...
- Full Text:
- Date Issued: 2023/02
- Authors: Adepoju, Abiola Victor , Ademola, Adelekan , Oladimeji, Olanrewaju
- Date: 2023/02
- Subjects: Tuberculosis , Patent medicine vendors , Community pharmacists , Anti-TB medication , Stocking , Dispensing , Fixed-dose combination
- Language: English
- Type: Article
- Identifier: http://hdl.handle.net/11260/13378 , vital:78665 , DOI: 10.3390/healthcare11040584
- Description: Background: Evidence has shown that non-fixed-dose combination (non-FDC) anti-TB drugs could promote the spread of drug-resistant tuberculosis (DR-TB). We aimed to determine anti-TB medication stocking and dispensing practices among patent medicine vendors (PMVs) and community pharmacists (CPs) and their determinants. Method: This was a cross-sectional study using a structured, self-administered questionnaire among 405 retail outlets (322 PMVs and 83 CPs) across 16 Lagos and Kebbi local government areas (LGAs) between June 2020 and December 2020. Data were analyzed with Statistical Program for Social Sciences (SPSS) for Windows version 17 (IBM Corp., Armonk, NY, USA). Chi-square test and binary logistic regression were used to assess the determinants of anti-TB medication stocking practices at a p-value of 0.05 or less for statistical significance. Results: Overall, 91%, 71%, 49%, 43% and 35% of the respondents reported stocking loose rifampicin, streptomycin, pyrazinamide, isoniazid and ethambutol tablets, respectively...
- Full Text:
- Date Issued: 2023/02
- «
- ‹
- 1
- ›
- »